Development of cationic lipophilic vancomycin analogues against bacterial biofilms and intracellular pathogens

Sarkar, Paramita

dc.contributor.advisor	Haldar, Jayanta
dc.contributor.author	Sarkar, Paramita
dc.date.accessioned	2019-07-23T06:12:39Z
dc.date.available	2019-07-23T06:12:39Z
dc.date.issued	2016
dc.identifier.citation	Sarkar, Paramita. 2016, Development of cationic lipophilic vancomycin analogues against bacterial biofilms and intracellular pathogens, MS thesis, Jawaharlal Nehru Centre for Advanced Scientific Research, Bengaluru	en_US
dc.identifier.uri	https://libjncir.jncasr.ac.in/xmlui/handle/10572/2700
dc.description	Restricted access
dc.description.abstract	Bacterial infectious diseases: A growing global health concern With the emergence of antimicrobial resistance, infectious diseases have been proclaimed as one of the greatest threats to global human health by the World Health Organization (WHO).1 Infectious diseases are caused by microorganisms such as bacteria, viruses, fungi and parasites and spread, directly or indirectly, from one person to another. Globally, infectious diseases caused by bacteria contribute to approximately 20 % of overall burden of infectious diseases. India is a hotspot for infectious diseases, occupying the highest position for the occurrence of bacterial infections in the world.	en_US
dc.language.iso	English	en_US
dc.publisher	Jawaharlal Nehru Centre for Advanced Scientific Research	en_US
dc.rights	© 2016 JNCASR
dc.subject	Drug development	en_US
dc.title	Development of cationic lipophilic vancomycin analogues against bacterial biofilms and intracellular pathogens	en_US
dc.type	Thesis	en_US
dc.type.qualificationlevel	Master	en_US
dc.type.qualificationname	MS	en_US
dc.publisher.department	New Chemistry Unit (NCU)	en_US